IRTC - iRhythm Technologies Inc Stock Price, Fair Value and News

112.15USD+0.88 (+0.79%)Delayed as of 26 Apr 2024, 10:56 am ET

Market Summary

USD112.15+0.88

Delayedas of 26 Apr 2024, 10:56 am

0.79%

IRTC Stock Price

View Fullscreen

IRTC RSI Chart

IRTC Valuation

Market Cap

3.4B

Price/Earnings (Trailing)

-27.93

Price/Sales (Trailing)

EV/EBITDA

-33.57

Price/Free Cashflow

-38.08

IRTC Price/Sales (Trailing)

IRTC Profitability

Operating Margin

67.35%

EBT Margin

-24.90%

Return on Equity

-58.74%

Return on Assets

-28.49%

Free Cashflow Yield

-2.63%

IRTC Fundamentals

IRTC Revenue

Revenue (TTM)

492.7M

Rev. Growth (Yr)

17.67%

Rev. Growth (Qtr)

6.35%

IRTC Earnings

Earnings (TTM)

-123.4M

Earnings Growth (Yr)

-91.6%

Earnings Growth (Qtr)

-42.72%

Breaking Down IRTC Revenue

52 Week Range

81.81135.80

(Low)(High)

Last 7 days

-0.8%

Last 30 days

-3.3%

Last 90 days

-5.3%

Trailing 12 Months

-17.8%

How does IRTC drawdown profile look like?

IRTC Financial Health

Current Ratio

2.15

Debt/Equity

0.17

Debt/Cashflow

-1.43

IRTC Investor Care

Shares Dilution (1Y)

2.52%

Diluted EPS (TTM)

-4.05

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	430.0M	452.1M	472.8M	492.7M
2022	340.9M	361.7M	380.1M	410.9M
2021	275.9M	306.3M	319.8M	322.8M
2020	229.8M	228.2M	245.5M	265.2M
2019	163.8M	181.0M	197.2M	214.6M
2018	108.8M	120.3M	133.7M	147.3M
2017	72.7M	80.8M	89.0M	98.5M
2016	41.9M	48.8M	56.2M	64.1M
2015	25.3M	28.9M	32.5M	36.1M
2014	0	0	0	21.7M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of iRhythm Technologies Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 04, 2024	shrishrimal sumi	sold	-80,354	111	-723	evp, chief risk officer
Mar 04, 2024	day mark j.	sold	-360,983	111	-3,248	chief technology officer
Mar 04, 2024	murphy patrick michael	sold	-169,488	111	-1,525	cbo and clo
Mar 04, 2024	patterson chad	sold	-119,698	111	-1,077	chief commercial officer
Mar 04, 2024	blackford quentin s.	sold	-469,122	111	-4,221	president and ceo
Mar 04, 2024	bobzien brice	sold	-155,707	111	-1,401	chief financial officer
Mar 04, 2024	wilson daniel g.	sold	-272,515	111	-2,452	evp, corp dev inv rel
Mar 04, 2024	turakhia minang	sold	-104,805	111	-943	evp, cmo & cso
Feb 29, 2024	murphy patrick michael	sold	-928,725	121	-7,615	cbo and clo
Feb 29, 2024	blackford quentin s.	sold	-3,012,530	121	-24,701	president and ceo

Which funds bought or sold IRTC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 24, 2024	AlphaCentric Advisors LLC	sold off	-100	-535,200	-	-%
Apr 24, 2024	Assenagon Asset Management S.A.	added	9.48	193,507	1,231,690	-%
Apr 23, 2024	FIFTH THIRD BANCORP	unchanged	-	806	10,440	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-76.5	-351,000	120,000	-%
Apr 23, 2024	BFSG, LLC	unchanged	-	107	1,392	-%
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	reduced	-0.61	20,266	283,156	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	204,838	1,715,640	0.01%
Apr 19, 2024	Financial Perspectives, Inc	reduced	-97.95	-35,839	812	-%
Apr 18, 2024	Diversified Trust Co	added	148	359,977	572,344	0.02%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	added	13.44	8,981,630	48,143,100	0.07%

Are Funds Buying or Selling IRTC?

Are funds buying IRTC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own IRTC

No. of Funds

Unveiling iRhythm Technologies Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	9.77%	2,993,443	SC 13G/A
Feb 13, 2024	sands capital management, llc	7.3%	2,237,750	SC 13G/A
Feb 12, 2024	artisan partners limited partnership	6.8%	2,071,500	SC 13G
Feb 09, 2024	capital research global investors	8.1%	2,495,626	SC 13G
Jan 25, 2024	blackrock inc.	8.1%	2,494,403	SC 13G/A
Feb 14, 2023	sands capital management, llc	9.1%	2,667,428	SC 13G/A
Feb 09, 2023	vanguard group inc	9.55%	2,876,849	SC 13G/A
Jan 31, 2023	blackrock inc.	7.6%	2,288,507	SC 13G/A
Jan 27, 2023	mackenzie financial corp	4.14%	1,246,524	SC 13G/A
Nov 07, 2022	jpmorgan chase & co	4.0%	1,225,734	SC 13G/A

Recent SEC filings of iRhythm Technologies Inc

View All Filings

Date Filed	Form Type	Document
Apr 15, 2024	4/A	Insider Trading
Apr 15, 2024	4/A	Insider Trading
Apr 11, 2024	ARS	ARS
Apr 11, 2024	DEF 14A	DEF 14A
Apr 11, 2024	DEFA14A	DEFA14A
Mar 28, 2024	PRE 14A	PRE 14A
Mar 08, 2024	8-K	Current Report
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	8-K	Current Report
Mar 05, 2024	4	Insider Trading

Peers (Alternatives to iRhythm Technologies Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	185.5B	40.1B	-4.14%	-1.72%	32.41	4.62	-8.12%	-17.45%
BDX	66.6B	19.5B	-4.72%	-10.85%	53.01	3.42	4.02%	-22.04%
ALGN	23.3B	3.9B	-2.96%	-12.43%	52.39	6.04	3.42%	23.09%
BAX	20.4B	14.8B	-3.18%	-12.72%	7.69	1.38	2.12%	209.17%
MID-CAP
HSIC	9.4B	12.3B	-0.07%	-10.32%	22.5	0.76	-2.44%	-22.68%
ATR	9.3B	3.5B	-1.98%	21.26%	32.53	2.65	4.97%	18.89%
BIO	8.0B	2.7B	-19.10%	-36.82%	-12.63	3.01	-4.68%	82.43%
XRAY	6.3B	4.0B	-6.58%	-25.82%	-46.81	1.59	1.10%	85.84%
AXNX	3.4B	366.4M	-3.44%	15.93%	-559.2	9.26	33.86%	89.83%
PDCO	2.3B	6.6B	-4.62%	-2.20%	11.94	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-14.98%	-16.46%	-1.88	0.4	7.73%	-1066.14%
ANIK	379.9M	166.7M	0.99%	-2.77%	-4.6	2.28	6.67%	-456.34%
ANGO	231.5M	324.0M	7.22%	-30.16%	-1.2	0.71	-3.19%	-337.41%
APYX	51.3M	52.3M	13.28%	-50.68%	-2.74	0.98	17.61%	19.28%
AEMD	3.9M	3.7M	-14.29%	284.62%	-0.32	1.05	5.77%	8.23%

iRhythm Technologies Inc News

Latest updates

iRhythm Technologies Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	6.3%	132,511,000	124,604,000	124,130,000	111,436,000	112,617,000	103,875,000	102,051,000	92,378,000	81,804,000	85,432,000	81,278,000	74,311,000	78,809,000	71,944,000	50,878,000	63,535,000	59,104,000	54,673,000	52,441,000	48,334,000	41,782,000
Cost Of Revenue	7.0%	45,085,000	42,130,000	37,905,000	35,755,000	33,910,000	32,954,000	31,806,000	30,619,000	30,521,000	29,284,000	25,995,000	23,458,000	20,498,000	18,232,000	15,484,000	16,063,000	13,915,000	13,785,000	13,012,000	11,773,000	10,806,000
Gross Profit	6.0%	87,426,000	82,474,000	86,225,000	75,681,000	78,707,000	70,921,000	70,245,000	61,759,000	51,283,000	56,148,000	55,283,000	50,853,000	58,311,000	53,712,000	35,394,000	47,472,000	45,189,000	40,888,000	39,429,000	36,561,000	30,976,000
Operating Expenses	15.0%	126,608,000	110,077,000	105,097,000	115,185,000	99,405,000	92,007,000	93,696,000	110,308,000	83,482,000	79,430,000	72,275,000	78,323,000	67,892,000	58,469,000	55,556,000	56,645,000	62,915,000	59,148,000	49,994,000	44,765,000	44,067,000
S&GA Expenses	6.8%	100,114,000	93,768,000	91,420,000	100,343,000	86,730,000	80,559,000	81,751,000	73,158,000	71,612,000	70,745,000	62,669,000	69,813,000	56,288,000	49,701,000	43,014,000	48,230,000	53,647,000	45,649,000	42,161,000	38,066,000	36,983,000
R&D Expenses	-5.5%	15,416,000	16,309,000	13,677,000	14,842,000	12,675,000	11,448,000	11,945,000	10,542,000	11,870,000	8,685,000	9,606,000	8,510,000	11,604,000	8,768,000	12,542,000	8,415,000	9,268,000	13,499,000	7,833,000	6,699,000	7,084,000
EBITDA Margin	-14.9%	-0.21	-0.18	-0.18	-0.20	-0.24	-0.29	-0.32	-0.32	-0.28	-0.21	-0.16	-	-	-	-	-	-	-	-	-	-
Interest Expenses	1.5%	941,000	927,000	832,000	950,000	1,013,000	614,000	482,000	2,029,000	248,000	279,000	307,000	335,000	374,000	384,000	381,000	380,000	385,000	409,000	440,000	409,000	535,000
Income Taxes	30.8%	255,000	195,000	213,000	87,000	73,000	116,000	33,000	47,000	59,000	94,000	116,000	98,000	-24,000	105,000	131,000	17,000	18,000	20,000	15,000	12,000	44,000
Earnings Before Taxes	-42.8%	-38,444,000	-26,921,000	-18,269,000	-39,022,000	-20,125,000	-21,335,000	-23,864,000	-50,562,000	-32,432,000	-23,637,000	-17,244,000	-27,681,000	-9,675,000	-4,572,000	-20,306,000	-9,048,000	-17,282,000	-18,273,000	-10,710,000	-8,238,000	-16,755,000
EBT Margin	-12.8%	-0.25	-0.22	-0.22	-0.24	-0.28	-0.34	-0.36	-0.36	-0.31	-0.24	-0.19	-	-	-	-	-	-	-	-	-	-
Net Income	-42.7%	-38,699,000	-27,116,000	-18,482,000	-39,109,000	-20,198,000	-21,451,000	-23,897,000	-50,609,000	-32,491,000	-23,731,000	-17,360,000	-27,779,000	-9,651,000	-4,677,000	-20,437,000	-9,065,000	-17,300,000	-18,293,000	-10,725,000	-8,250,000	-16,270,000
Net Income Margin	-12.9%	-0.25	-0.22	-0.22	-0.24	-0.28	-0.34	-0.36	-0.36	-0.31	-0.25	-0.19	-	-	-	-	-	-	-	-	-	-
Free Cashflow	-273.7%	-29,489,000	-7,891,000	-13,969,000	-39,176,000	5,483,000	-2,664,000	-11,204,000	-44,457,000	-17,670,000	4,369,000	-6,466,000	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-1.5%	433	440	429	422	448	440	436	429	463	480	485	478	512	497	276	283	306	310	205	115	118
Current Assets	-1.5%	231	234	242	254	289	286	285	286	306	325	336	336	378	366	147	154	173	185	92.00	92.00	104
Cash Equivalents	-23.8%	36.00	47.00	62.00	53.00	79.00	71.00	101	95.00	128	167	139	137	89.00	95.00	82.00	57.00	20.00	35.00	16.00	28.00	20.00
Inventory	2.4%	14.00	14.00	14.00	16.00	15.00	14.00	14.00	12.00	10.00	10.00	9.00	7.00	5.00	5.00	5.00	4.00	4.00	3.00	3.00	3.00	2.00
Net PPE	7.7%	104	97.00	90.00	82.00	76.00	72.00	66.00	57.00	56.00	53.00	47.00	37.00	34.00	33.00	30.00	28.00	26.00	18.00	13.00	10.00	9.00
Goodwill	0%	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Liabilities	1.4%	223	220	206	200	208	201	191	184	183	184	179	169	170	163	158	158	171	167	159	68.00	65.00
Current Liabilities	5.0%	107	102	89.00	82.00	89.00	84.00	70.00	62.00	88.00	83.00	73.00	59.00	66.00	56.00	47.00	43.00	52.00	45.00	35.00	29.00	30.00
Long Term Debt	0.0%	35.00	35.00	35.00	35.00	35.00	35.00	35.00	35.00	10.00	13.00	16.00	18.00	21.00	24.00	27.00	30.00	33.00	35.00	35.00	35.00	35.00
LT Debt, Non Current	0.0%	35.00	35.00	35.00	35.00	35.00	35.00	35.00	35.00	10.00	13.00	16.00	18.00	21.00	24.00	27.00	30.00	33.00	35.00	35.00	35.00	35.00
Shareholder's Equity	-4.4%	210	220	224	222	240	239	245	245	280	296	306	310	342	335	118	125	135	143	47.00	48.00	52.00
Retained Earnings	-6.4%	-645	-606	-579	-561	-522	-502	-480	-456	-406	-373	-349	-332	-304	-295	-290	-269	-260	-243	-224	-214	-205
Additional Paid-In Capital	3.5%	856	827	804	783	762	742	726	702	686	669	656	642	646	629	408	395	396	386	271	262	258
Shares Outstanding	1.0%	31.00	31.00	31.00	30.00	30.00	30.00	30.00	30.00	29.00	29.00	29.00	-	-	-	-	-	-	-	-	-	-
Float	-	-	-	3,200	-	-	-	3,200	-	-	-	1,900	-	-	-	3,100	-	-	-	1,950	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-1435.5%	-15,972	1,196	-4,572	-30,753	12,576	3,669	-372	-38,885	-13,045	17,677	-543	-41,842	7,818	10,942	-10,153	-22,366	-4,860	-861	1,021	-17,163	-4,373
Share Based Compensation	13.5%	23,846	21,008	14,099	18,251	15,794	12,945	15,098	13,903	11,877	12,160	10,260	20,230	13,998	17,444	9,768	305	7,177	7,401	6,807	4,856	4,795
Cashflow From Investing	109.1%	1,400	-15,438	9,009	3,820	-8,114	-35,362	-431	-8,527	-27,133	13,660	1,702	117,035	-17,485	-204,481	29,664	59,911	-12,508	-87,063	-16,082	26,379	4,294
Cashflow From Financing	5154.5%	3,468	66.00	4,381	905	3,148	1,662	7,270	14,636	369	-2,838	338	-26,446	2,959	207,145	5,705	-1,493	3,196	106,574	2,944	-1,138	2,757

IRTC Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue, net	$ 492,681	$ 410,921	$ 322,825
Cost of revenue	160,875	129,289	109,258
Gross profit	331,806	281,632	213,567
Operating expenses:
Research and development	60,244	46,610	38,671
Selling, general and administrative	385,645	322,198	274,839
Impairment and restructuring charges	11,078	26,608	0
Total operating expenses	456,967	395,416	313,510
Loss from operations	(125,161)	(113,784)	(99,943)
Interest expense	(3,650)	(4,138)	(1,169)
Interest and other income, net	6,155	2,036	118
Loss before income taxes	(122,656)	(115,886)	(100,994)
Income tax provision	750	269	367
Net loss	$ (123,406)	$ (116,155)	$ (101,361)
Net loss per common share, basic (in USD per share)	$ (4.04)	$ (3.88)	$ (3.46)
Net loss per common share, diluted (in USD per share)	$ (4.04)	$ (3.88)	$ (3.46)
Weighted-average shares, basic (in shares)	30,528	29,916	29,331
Weighted-average shares, diluted (in shares)	30,528	29,916	29,331

IRTC Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 36,173	$ 78,832
Marketable securities	97,591	134,312
Accounts receivable, net	61,484	49,918
Inventory	13,973	15,155
Prepaid expenses and other current assets	21,591	10,555
Total current assets	230,812	288,772
Property and equipment, net	104,114	75,670
Operating lease right-of-use assets	49,317	60,666
Goodwill	862	862
Other assets	48,039	22,252
Total assets	433,144	448,222
Current liabilities:
Accounts payable	5,543	7,517
Accrued liabilities	83,362	65,497
Deferred revenue	3,306	3,051
Operating lease liabilities, current portion	15,159	13,031
Total current liabilities	107,370	89,096
Debt, noncurrent portion	34,950	34,935
Other noncurrent liabilities	1,012	1,307
Operating lease liabilities, noncurrent portion	79,715	83,072
Total liabilities	223,047	208,410
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.001 par value – 5,000 shares authorized; none issued and outstanding at December 31, 2023 and 2022	0	0
Common stock, $0.001 par value – 100,000 shares authorized; 30,954 and 30,193 shares issued and outstanding at December 31, 2023 and 2022, respectively	31	28
Additional paid-in capital	855,784	762,380
Accumulated other comprehensive loss	(112)	(396)
Accumulated deficit	(645,606)	(522,200)
Total stockholders’ equity	210,097	239,812
Total liabilities and stockholders’ equity	$ 433,144	$ 448,222

About iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

CEO	Mr. Quentin S. Blackford
WEBSITE	irhythmtech.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	1793

iRhythm Technologies Inc Frequently Asked Questions

What is the ticker symbol for iRhythm Technologies Inc? What does IRTC stand for in stocks?

IRTC is the stock ticker symbol of iRhythm Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of iRhythm Technologies Inc (IRTC)?

As of Thu Apr 25 2024, market cap of iRhythm Technologies Inc is 3.45 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IRTC stock?

You can check IRTC's fair value in chart for subscribers.

What is the fair value of IRTC stock?

You can check IRTC's fair value in chart for subscribers. The fair value of iRhythm Technologies Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of iRhythm Technologies Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for IRTC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is iRhythm Technologies Inc a good stock to buy?

The fair value guage provides a quick view whether IRTC is over valued or under valued. Whether iRhythm Technologies Inc is cheap or expensive depends on the assumptions which impact iRhythm Technologies Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IRTC.

What is iRhythm Technologies Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 25 2024, IRTC's PE ratio (Price to Earnings) is -27.93 and Price to Sales (PS) ratio is 7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IRTC PE ratio will change depending on the future growth rate expectations of investors.